Maybe we should give up on PBT2 and start selling that PLACEBO
We have a drug that
arrests brain volume reduction
Improves cognition in HD and AD
Alters CSF aBeta
and needs to be studied at higher doses to show statistical significance
Still the most promising treatment if the higher dose is safe
Frustrating nonetheless and company needs to show the full data to allow us to understand what happened and update extension study which is obviously still going
pbt - an investment view (imo), page-32
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.96M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.3¢ | $3.516K | 1.112M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 75 | 108230584 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 151421887 | 64 |
View Market Depth
| Last trade - 13.21pm 06/11/2024 (20 minute delay) ? |
| ATH (ASX) Chart |